Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Testosterone for Prevention of Recurrent UTI in Postmenopausal Women
NCT04807894Phase 4Terminated
- Sponsor
- Jefferson Drapkin
- Start
- Nov 2020
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in urinary tract infection (UTI) comparing Vaginal Testosterone Cream Arm with Vaginal Placebo Cream Arm (2 arms). Primary endpoints: Incidence of urinary tract infections at 9 months and Change in vaginal flora and pH at 9 months. Started Nov 2020; status: terminated.
02
Drugs
testosterone
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04807894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04807894.